In the News
Read articles that highlight the groundbreaking research and scientific discoveries being led by MSK’s extraordinary team.
Investigators Look Beyond Immune Checkpoint Inhibitors to Chase Moving Targets in Prostate Cancer
ASCO CEO Dr. Clifford A. Hudis wraps up our final Morning Minute with some helpful reminders, and his wish for next year.
VISION: Implementation of Lutetium-177-PSMA-617 in Metastatic Castration-Resistant Prostate Cancer Approaches Reality
Memorial Sloan Kettering AI spinout, Quest Diagnostics partner to expedite cancer diagnoses
Dr. Dang on Cardiac Safety With Pertuzumab/ Trastuzumab in Early-Stage HER2+ Breast Cancer
Dr. Giralt on Omidubicel Vs Standard Umbilical Cord Blood Transplant in Hematologic Malignancies
Find more news and updates on MSK’s cancer care and research breakthroughs.